STN: 125740
Proper Name: Tick-Borne Encephalitis Vaccine
Tradename: TICOVAC
Manufacturer: Pfizer Ireland Pharmaceuticals
Indication:

• For active immunization to prevent tick-borne encephalitis (TBE) in individuals 1 year of age and older.

Product Information

• Package Insert - TICOVAC

Supporting Documents

• August 13, 2021 Approval Letter - TICOVAC
• August 13, 2021 Summary Basis for Regulatory Action - TICOVAC
• August 13, 2021 Clinical Review Memo - TICOVAC
• Statistical Review - TICOVAC
• Approval History, Letters, Reviews, and Related Documents - TICOVAC